search
Back to results

The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms

Primary Purpose

Obsessive-Compulsive Disorder/High Compulsive Individuals, Healthy Individuals

Status
Recruiting
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
Escitalopram
Placebo oral tablet
Sponsored by
Rigshospitalet, Denmark
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Obsessive-Compulsive Disorder/High Compulsive Individuals focused on measuring Serotonin, Cognition, Emotion, Neural Activation

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • OCD patients and healthy volunteers (male or female) between 18 and 70 years.

Exclusion Criteria:

  • Current or previous neurological disease, severe somatic disease, or consumption of medical drugs likely to influence the test results
  • Non- fluent in Danish or pronounced visual or auditory impairments
  • Current or past learning disability.
  • Pregnancy (females).
  • Lactation (females).
  • Participation in experiments with radioactivity (> 10 mSv) within the last year or significant occupational exposure to radioactivity.
  • Contraindications for MRI (pacemaker, metal implants, etc.).
  • Allergy to the ingredients in the administered drug.
  • Abnormal ECG (e.g. prolonged QT syndrome).
  • Dizzy when changing from supine to upright position (e.g. postural orthostatic tachycardia syndrome).
  • Mild hypotension (blood pressure below 100/70 mmHg) or hypertension (blood pressure above 140/90 mmHg).
  • Head injury or concussion resulting in loss of consciousness for more than 2 min.
  • Alcohol or drug abuse
  • Drug use other than tobacco and alcohol within the last 30 days.
  • Hash > 50 x lifetime.
  • Drugs > 10 x lifetime (for each substance).
  • Current medication with serotonergic acting compounds. Use of other psychoactive substances must be stable at least one month prior to inclusion and maintained throughout the study.
  • Severe physical impairments affecting eyesight or motor performance.
  • For the OCD group: other Axis I mental disorder as primary diagnosis according to ICD-10 criteria.
  • For healthy volunteers: any current or former primary psychiatric disorder (Axis I WHO ICD-10 diagnostic classification).

Sites / Locations

  • Neurobiology Research Unit, RigshospitaletRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Placebo Comparator

Experimental

Experimental

Arm Label

Healthy Control Group

Obsessive-Compulsive Disorder / High Compulsivity Control Group

Healthy Intervention Group

Obsessive-Compulsive Disorder / High Compulsivity Intervention Group

Arm Description

The healthy placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

The OCD/high compulsivity placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.

The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

The OCD/high compulsivity intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.

Outcomes

Primary Outcome Measures

Learning Primary Outcome 1 measured with Probability Reversal Learning test: Mean errors Stage 1 (Learning)
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Primary Outcome 2 measured with Probability Reversal Learning test: Mean errors Stage 2 (Reversal)
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Primary Outcome 3 measured with Deterministic Reversal Learning test: Percent correct per stage
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Inhibition Primary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Stop Signal Reaction Time
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Flexibility Primary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Extra Dimensional Set Errors
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Flexibility Primary Outcome 2 measured with Sequential model-based model-free test: Model-based Model-free Weight
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Social Cognition Primary Outcome 1 measured with EMOTICOM Moral Emotions Task: Agent Guilt Score
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Social Cognition Primary Outcome 2 measured with EMOTICOM Moral Emotions Task: Agent Shame Score
Outcome variables have been grouped a priori into carefully defined cognitive domains. The false discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Primary Outcome 1 measures with EMOTICOM Intensity Morphing: Affective bias in decreasing condition
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Primary Outcome 2 measured with EMOTICOM Emotion Recognition Task: Affective bias for D'
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Primary Outcome 3 measured with EMOTICOM Intensity Morphing task: Detection threshold decreasing
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Primary Outcome 4 measured with EMOTICOM Emotion Recognition task: D'Prime for emotion recognition
Emotion Recognition Task. Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Memory Primary Outcome 1 measured with CANTAB Paired Associates Learning: Total Errors Adj
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Biofluids
Serum Escitalopram levels
Positron emission tomography (PET) Imaging: Cerebral [11C]SB207145 PET binding.
Collected before and after participant's intervention.
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Slip of Actions
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Cohabit
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12Co-habit fMRI paradigm Imaging outcomes will be FWE corrected using Random Field Theory as implemented in SPM12.
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Faces
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Resting State fMRI
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Structural Voxel-based morphometry (VBM) MRI
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Diffusion Tensor Imaging MRI
Habit formation outcome 1: response times for each day of training
Daily app training paradigm
Habit formation outcome 2: mean errors per sequence and moves
Daily app training paradigm
Habit formation outcome 3: confidence and enjoyable rates.
Daily app training paradigm

Secondary Outcome Measures

Learning Secondary Outcome 1 measured with Probability Reversal Learning test: Stage 1 Reward-Stay/Lose-Shift behaviour
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 2 measured with Probability Reversal Learning test: Stage 1 Reward/Punishment learning
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 3 measured with Probability Reversal Learning test: Stage 1. Stimulus Stickiness
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 4 measured with Probability Reversal Learning test: Stage 2 Reward-Stay/ Lose-Shift behaviour
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 5 measured with Probability Reversal Learning test: Stage 2 Reward/Punishment learning
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 6 measured with Probability Reversal Learning test: Stage 2. Stimulus Stickiness
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Learning Secondary Outcome 7 measured with Deterministic Reversal Learning test: Reward-Stay/ Lose-Shift behaviour
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 1 measured with Sequential Model-Based/Model-Free test: Proportion of Stays
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 2 measured with Sequential Model-Based/Model-Free test: Exploration
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 3 measured with Sequential Model-Based/Model-Free test: Stimulus Stickiness
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 4 measured with Sequential Model-Based/Model-Free test: Learning rate
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 5 measured with 3Dimensional Intra/Extra Dimensional Shift test: Pre Extra Dimension Set Errors
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Flexibility Secondary Outcome 6 measured with 3Dimensional Intra/Extra Dimensional Shift test: Latency
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Inhibition Secondary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Go reaction time
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Inhibition Secondary Outcome 2 measured with Interleaved Stop Signal Task/Go-NoGo: Go omission error rate
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Inhibition Secondary Outcome 3 measured with Interleaved Stop Signal Task/Go-NoGo: Go commission error rate
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Inhibition Secondary Outcome 4 measured with Interleaved Stop Signal Task/Go-NoGo: No-Go error rate
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Executive Function Secondary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Total Errors Adjusted
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Secondary Outcome 1 measured with EMOTICOM Intensity Morphing Task: Detection threshold increasing
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Secondary Outcome 2 measured with EMOTICOM Intensity Morphing Task: Affective bias in increasing condition
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Secondary Outcome 3 measured with EMOTICOM Emotion Recognition Task: Affective bias for Hit Rate
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Emotion Recognition Secondary Outcome 4 measured with EMOTICOM Emotion Recognition Task.: Hit Rate for Emotion Recognition
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Faces and geometric figure discrimination Outcome 1 measured with fMRI faces paradigm: Accuracy
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Behavioural outcomes with Faces and geometric figure discrimination Outcome 2 measured with fMRI faces paradigm: Response Speed
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Behavioural outcomes with fMRI paradigm slip of Actions : accuracy and latency
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Behavioural outcomes with fMRI paradigm Co-habit: accuracy and latency.
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Memory Outcome 1 measured with CANTAB Paired Associates Learning test: First Trial Memory Score
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Memory Outcome 2 measured with Letter-number sequencing test: Total score
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Memory Primary outcome 3 measured with Verbal Affective Memory Test-26: Latent variable model of the association between positive, negative and neutral word recall and 5-HT4R binding
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Risky Decision Making Outcome Outcome 1 measured with EMOTICOM Cambridge Gamble Task: Quality of Decision Making
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Risky Decision Making Outcome 2 measured with EMOTICOM Cambridge Gamble Task: Risk Adjustment
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Risky Decision Making Outcome 3 measured with EMOTICOM Cambridge Gamble Task: Overall Proportion Bet
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Risky Decision Making Outcome 4 measured with EMOTICOM Cambridge Gamble Task: Deliberation Time
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Psychomotor Speed Outcome 1 measured with CANTAB Reaction Time Task: Simple reaction time
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Intelligence Quotient (IQ) outcome 1 measured with Reynolds Intellectual assessment Scales subtest "guess what" and "what does not fit": Total age adjusted score
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain
Interpersonal Reactivity Index (IRI) Score
Obsessive- Compulsive Inventory (OCI)- state Score
Obsessive- Compulsive Inventory- trait Score
Brief Symptom Inventory (BSI) Score
Pittsburgh Sleep Quality Index Score
Profile of Mood State Score
Beck Depression Inventory-II Score
Contain 21-items, scored on a scale value of 0 to 3
State-Trait Anxiety Inventory Scale Score
Contain 40-items
State and Trait Aggression Questionnaire Score
Barratt Impulsiveness Scale-State Score
Visual Analogue Scale Score

Full Information

First Posted
March 25, 2020
Last Updated
November 17, 2022
Sponsor
Rigshospitalet, Denmark
Collaborators
University of Cambridge, Lundbeck Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT04336228
Brief Title
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
Official Title
The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2020 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rigshospitalet, Denmark
Collaborators
University of Cambridge, Lundbeck Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this project is to investigate: The status of the central serotonin (5-hydroxytryptamine, 5-HT) system in compulsive behaviour and how it is affected by sub-chronic escitalopram administration The mechanisms underlying how sub-chronic administration of escitalopram affects the central 5-HT system How changes in cognitive performance, including the balance between habitual and goal-directed mechanisms, are affected in compulsive behaviour by boosting 5-HT function How functional brain changes in cognitive function measured with magnetic resonance imaging relate to altered 5-HT function following escitalopram administration.
Detailed Description
Previous studies have shown that 5-HT is strongly implicated in compulsive behaviours in experimental animals. Manipulation of 5-HT influences neuronal interactions underlying action selection. Reduced forebrain 5-HT causes perseveration and impairs goal-directed behaviour under reward but not punishment. Dysfunctional 5-HT neurotransmission has also been implicated in Obsessive-Compulsive Disorder (OCD) based on the selective efficacy of relatively high doses of selective serotonin reuptake inhibitors (SSRIs) in treating this disorder. Hitherto, it is unknown whether there is a primary defect in the serotonergic system or whether SSRIs ameliorate symptoms by modulating other brain neurotransmitter pathways. So far, only one study of central 5-HT release in OCD patients has been conducted and its methodology may be questioned. A number of behavioural and cognitive features of OCD, including endophenotype markers that appear to characterise the disorder have been determined. These include a shift in cognitive control from a goal-directed strategy to a habitual (stimulus-response, S-R) strategy, cognitive rigidity in terms of both reversal learning and attentional set-shifting, impaired response inhibition and planning, and a tendency to over-respond to spurious negative feedback in a probabilistic learning paradigm. Neural substrates of these deficits are being investigated using brain imaging methodologies based on magnetic resonance and preliminary evidence suggests an over-active medial prefrontal cortex-caudate nucleus circuits and underactive lateral prefrontal cortex-putamen circuits. However, little evidence exists that relates to the hypothesis of an over-active habit system in this disorder or to the role of serotonin in all these cognitive and behavioural deficits observed in OCD and compulsivity in general.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive-Compulsive Disorder/High Compulsive Individuals, Healthy Individuals
Keywords
Serotonin, Cognition, Emotion, Neural Activation

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Healthy Control Group
Arm Type
Placebo Comparator
Arm Description
The healthy placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.
Arm Title
Obsessive-Compulsive Disorder / High Compulsivity Control Group
Arm Type
Placebo Comparator
Arm Description
The OCD/high compulsivity placebo control group will be administered the exact same procedure as the intervention group, the only difference being that this group will be administered a placebo tablet.
Arm Title
Healthy Intervention Group
Arm Type
Experimental
Arm Description
The healthy intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.
Arm Title
Obsessive-Compulsive Disorder / High Compulsivity Intervention Group
Arm Type
Experimental
Arm Description
The OCD/high compulsivity intervention group will be administered 20mg of Escitalopram daily for 3-4 weeks.
Intervention Type
Drug
Intervention Name(s)
Escitalopram
Other Intervention Name(s)
Escitalopram STADA
Intervention Description
20mg daily for 3-4 weeks.
Intervention Type
Drug
Intervention Name(s)
Placebo oral tablet
Other Intervention Name(s)
calcium tables
Intervention Description
20mg placebo tablet daily for 3-4 weeks.
Primary Outcome Measure Information:
Title
Learning Primary Outcome 1 measured with Probability Reversal Learning test: Mean errors Stage 1 (Learning)
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 years
Title
Learning Primary Outcome 2 measured with Probability Reversal Learning test: Mean errors Stage 2 (Reversal)
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Primary Outcome 3 measured with Deterministic Reversal Learning test: Percent correct per stage
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Inhibition Primary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Stop Signal Reaction Time
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Flexibility Primary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Extra Dimensional Set Errors
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Flexibility Primary Outcome 2 measured with Sequential model-based model-free test: Model-based Model-free Weight
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Social Cognition Primary Outcome 1 measured with EMOTICOM Moral Emotions Task: Agent Guilt Score
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Social Cognition Primary Outcome 2 measured with EMOTICOM Moral Emotions Task: Agent Shame Score
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. The false discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Primary Outcome 1 measures with EMOTICOM Intensity Morphing: Affective bias in decreasing condition
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Primary Outcome 2 measured with EMOTICOM Emotion Recognition Task: Affective bias for D'
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Primary Outcome 3 measured with EMOTICOM Intensity Morphing task: Detection threshold decreasing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Primary Outcome 4 measured with EMOTICOM Emotion Recognition task: D'Prime for emotion recognition
Description
Emotion Recognition Task. Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Memory Primary Outcome 1 measured with CANTAB Paired Associates Learning: Total Errors Adj
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Biofluids
Description
Serum Escitalopram levels
Time Frame
3 Years
Title
Positron emission tomography (PET) Imaging: Cerebral [11C]SB207145 PET binding.
Description
Collected before and after participant's intervention.
Time Frame
3 Years
Title
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Slip of Actions
Description
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Time Frame
3 Years
Title
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Cohabit
Description
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12Co-habit fMRI paradigm Imaging outcomes will be FWE corrected using Random Field Theory as implemented in SPM12.
Time Frame
3 Years
Title
Neural Activations and Correlations measured with functional magnetic resonance imaging (fMRI) paradigm named Faces
Description
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Time Frame
3 Years
Title
Resting State fMRI
Description
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Time Frame
3 Years
Title
Structural Voxel-based morphometry (VBM) MRI
Description
Imaging outcomes will be Family-Wise Error (FWE) corrected using Random Field Theory as implemented in SPM12.
Time Frame
3 Years
Title
Diffusion Tensor Imaging MRI
Time Frame
3 Years
Title
Habit formation outcome 1: response times for each day of training
Description
Daily app training paradigm
Time Frame
3 Years
Title
Habit formation outcome 2: mean errors per sequence and moves
Description
Daily app training paradigm
Time Frame
3 Years
Title
Habit formation outcome 3: confidence and enjoyable rates.
Description
Daily app training paradigm
Time Frame
3 Years
Secondary Outcome Measure Information:
Title
Learning Secondary Outcome 1 measured with Probability Reversal Learning test: Stage 1 Reward-Stay/Lose-Shift behaviour
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 2 measured with Probability Reversal Learning test: Stage 1 Reward/Punishment learning
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 3 measured with Probability Reversal Learning test: Stage 1. Stimulus Stickiness
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 4 measured with Probability Reversal Learning test: Stage 2 Reward-Stay/ Lose-Shift behaviour
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 5 measured with Probability Reversal Learning test: Stage 2 Reward/Punishment learning
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 6 measured with Probability Reversal Learning test: Stage 2. Stimulus Stickiness
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Learning Secondary Outcome 7 measured with Deterministic Reversal Learning test: Reward-Stay/ Lose-Shift behaviour
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 1 measured with Sequential Model-Based/Model-Free test: Proportion of Stays
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 2 measured with Sequential Model-Based/Model-Free test: Exploration
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 3 measured with Sequential Model-Based/Model-Free test: Stimulus Stickiness
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 4 measured with Sequential Model-Based/Model-Free test: Learning rate
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 5 measured with 3Dimensional Intra/Extra Dimensional Shift test: Pre Extra Dimension Set Errors
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Flexibility Secondary Outcome 6 measured with 3Dimensional Intra/Extra Dimensional Shift test: Latency
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Inhibition Secondary Outcome 1 measured with Interleaved Stop Signal Task/Go-NoGo: Go reaction time
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Inhibition Secondary Outcome 2 measured with Interleaved Stop Signal Task/Go-NoGo: Go omission error rate
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Inhibition Secondary Outcome 3 measured with Interleaved Stop Signal Task/Go-NoGo: Go commission error rate
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Inhibition Secondary Outcome 4 measured with Interleaved Stop Signal Task/Go-NoGo: No-Go error rate
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Executive Function Secondary Outcome 1 measured with 3Dimensional Intra/Extra Dimensional Shift test: Total Errors Adjusted
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Secondary Outcome 1 measured with EMOTICOM Intensity Morphing Task: Detection threshold increasing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Secondary Outcome 2 measured with EMOTICOM Intensity Morphing Task: Affective bias in increasing condition
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Secondary Outcome 3 measured with EMOTICOM Emotion Recognition Task: Affective bias for Hit Rate
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Emotion Recognition Secondary Outcome 4 measured with EMOTICOM Emotion Recognition Task.: Hit Rate for Emotion Recognition
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Faces and geometric figure discrimination Outcome 1 measured with fMRI faces paradigm: Accuracy
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Behavioural outcomes with Faces and geometric figure discrimination Outcome 2 measured with fMRI faces paradigm: Response Speed
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Behavioural outcomes with fMRI paradigm slip of Actions : accuracy and latency
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Behavioural outcomes with fMRI paradigm Co-habit: accuracy and latency.
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Memory Outcome 1 measured with CANTAB Paired Associates Learning test: First Trial Memory Score
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Memory Outcome 2 measured with Letter-number sequencing test: Total score
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Memory Primary outcome 3 measured with Verbal Affective Memory Test-26: Latent variable model of the association between positive, negative and neutral word recall and 5-HT4R binding
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Risky Decision Making Outcome Outcome 1 measured with EMOTICOM Cambridge Gamble Task: Quality of Decision Making
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Risky Decision Making Outcome 2 measured with EMOTICOM Cambridge Gamble Task: Risk Adjustment
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Risky Decision Making Outcome 3 measured with EMOTICOM Cambridge Gamble Task: Overall Proportion Bet
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Risky Decision Making Outcome 4 measured with EMOTICOM Cambridge Gamble Task: Deliberation Time
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Psychomotor Speed Outcome 1 measured with CANTAB Reaction Time Task: Simple reaction time
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain.
Time Frame
3 Years
Title
Intelligence Quotient (IQ) outcome 1 measured with Reynolds Intellectual assessment Scales subtest "guess what" and "what does not fit": Total age adjusted score
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains. False discovery rate (FDR) correction, for multiple comparisons, using the Benjamini-Hochberg procedure will be applied to the outcomes within each cognitive domain
Time Frame
3 Years
Title
Interpersonal Reactivity Index (IRI) Score
Time Frame
3 Years
Title
Obsessive- Compulsive Inventory (OCI)- state Score
Time Frame
3 Years
Title
Obsessive- Compulsive Inventory- trait Score
Time Frame
3 Years
Title
Brief Symptom Inventory (BSI) Score
Time Frame
3 Years
Title
Pittsburgh Sleep Quality Index Score
Time Frame
3 Years
Title
Profile of Mood State Score
Time Frame
3 Years
Title
Beck Depression Inventory-II Score
Description
Contain 21-items, scored on a scale value of 0 to 3
Time Frame
3 Years
Title
State-Trait Anxiety Inventory Scale Score
Description
Contain 40-items
Time Frame
3 Years
Title
State and Trait Aggression Questionnaire Score
Time Frame
3 Years
Title
Barratt Impulsiveness Scale-State Score
Time Frame
3 Years
Title
Visual Analogue Scale Score
Time Frame
3 Years
Other Pre-specified Outcome Measures:
Title
Emotion Recognition Other Outcome 1: Detection threshold decreasing Happy - Intensity Morphing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 2: Detection threshold decreasing Sad - Intensity Morphing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 3: Detection threshold decreasing Anger - Intensity Morphing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 4: Detection threshold decreasing Fear - Intensity Morphing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 5: Detection threshold decreasing Disgust - Intensity Morphing
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 6: D' Happy - Emotion Recognition Task
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 7: D' Sad - Emotion Recognition Task
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 8: D' Fear - Emotion Recognition Task
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Emotion Recognition Other Outcome 9: D' Anger - Emotion Recognition Task
Description
Outcome variables have been grouped a priori into carefully defined cognitive domains.
Time Frame
3 Years
Title
Activity Level Score
Time Frame
3 Years
Title
Behavioural Inhibition/ Behavioural Avoidance Scale Score
Time Frame
3 Years
Title
The Compulsive Personality Assessment Scale Score
Time Frame
3 Years
Title
Sexuality Questionnaire Score
Time Frame
3 Years
Title
Edinburgh Handedness Inventory Score
Time Frame
3 Years
Title
Revised NEO Personality Questionnaire Score
Time Frame
3 Years
Title
Family History Assessment Module Score
Time Frame
3 Years
Title
Positive Life Events Score
Time Frame
3 Years
Title
Stressful Life Events Score
Time Frame
3 Years
Title
Perceived stress scale
Time Frame
3 Years
Title
Barratt Impulsiveness Scale-Trait Score
Time Frame
3 Years
Title
The Penn State Worry Questionnaire- Trait Score
Time Frame
3 Years
Title
The Penn State Worry Questionnaire- State Score
Time Frame
3 Years
Title
The Self-Control Scale- Trait Score
Time Frame
3 Years
Title
The Self-Control Scale- State Score
Time Frame
3 Years
Title
State- Trait Anxiety Inventory- Trait Score
Time Frame
3 Years
Title
The Warwick-Edinburgh Mental Well-being Scale -State Score
Time Frame
3 Years
Title
The Warwick-Edinburgh Mental Well-being Scale -Trait Score
Time Frame
3 Years
Title
Mindful Attention and Awareness Scale -State Score
Time Frame
3 Years
Title
Mindful Attention and Awareness Scale -Trait Score
Time Frame
3 Years
Title
The Intolerance of Uncertainty Scale - Trait Score
Time Frame
3 Years
Title
The Intolerance of Uncertainty Scale - State Score
Time Frame
3 Years
Title
Verran and Snyder-Halpern (VSH) Sleep Scale Score
Time Frame
3 Years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: OCD patients, compulsive individuals without an OCD diagnosis, and healthy volunteers (male or female) between 18 and 70 years. Compulsive individuals without an OCD diagnosis are individuals without a history of psychiatric or other major medical conditions but scoring abnormally high on the Obsessive-Compulsive Inventory (OCI) questionnaire. Exclusion Criteria: Current or previous neurological disease, severe somatic disease, or consumption of medical drugs likely to influence the test results Non- fluent in Danish or pronounced visual or auditory impairments Current or past learning disability. Pregnancy (females). Lactation (females). Participation in experiments with radioactivity (> 10 mSv) within the last year or significant occupational exposure to radioactivity. Contraindications for MRI (pacemaker, metal implants, etc.). Allergy to the ingredients in the administered drug. Abnormal ECG (e.g. prolonged QT syndrome). Dizzy when changing from supine to upright position (e.g. postural orthostatic tachycardia syndrome). Mild hypotension (blood pressure below 100/70 mmHg) or hypertension (blood pressure above 140/90 mmHg). Head injury or concussion resulting in loss of consciousness for more than 2 min. Alcohol or drug abuse Drug use other than tobacco and alcohol within the last 30 days. Hash > 50 x lifetime. Drugs > 10 x lifetime (for each substance). Current medication with serotonergic acting compounds. Use of other psychoactive substances must be stable at least one month prior to inclusion and maintained throughout the study. Severe physical impairments affecting eyesight or motor performance. For the OCD group: other Axis I mental disorder as primary diagnosis according to ICD-10 criteria. For healthy volunteers: any current or former primary psychiatric disorder (Axis I WHO ICD-10 diagnostic classification).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gitte M. Knudsen, Professor
Phone
+45 35456720
Email
gitte@nru.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Trevor W. Robbins, Professor
Phone
(01223) 333551
Email
twr2@cam.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gitte M. Knudsen, Professor
Organizational Affiliation
Neurobiology Research Unit, Rigshospitalet
Official's Role
Study Chair
Facility Information:
Facility Name
Neurobiology Research Unit, Rigshospitalet
City
Copenhagen
ZIP/Postal Code
2100
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gitte M Knudsen, DMSc
Phone
+45 35456720
Email
gmk@nru.dk

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Upon completion of the study all data will be uploaded to the existing Center for Integrated Molecular Brain Imaging (CIMBI) Database. Researchers may apply for access to the data.
IPD Sharing Time Frame
Upon completion of the study.
IPD Sharing Access Criteria
Researchers may apply for access to the data.
IPD Sharing URL
https://www.cimbi.dk/
Citations:
PubMed Identifier
15131308
Citation
Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cognitive inflexibility after prefrontal serotonin depletion. Science. 2004 May 7;304(5672):878-80. doi: 10.1126/science.1094987.
Results Reference
background
PubMed Identifier
19400722
Citation
Dayan P, Huys QJ. Serotonin in affective control. Annu Rev Neurosci. 2009;32:95-126. doi: 10.1146/annurev.neuro.051508.135607.
Results Reference
background
PubMed Identifier
22325972
Citation
Palminteri S, Clair AH, Mallet L, Pessiglione M. Similar improvement of reward and punishment learning by serotonin reuptake inhibitors in obsessive-compulsive disorder. Biol Psychiatry. 2012 Aug 1;72(3):244-50. doi: 10.1016/j.biopsych.2011.12.028. Epub 2012 Feb 10.
Results Reference
background
PubMed Identifier
22763621
Citation
Pelloux Y, Dilleen R, Economidou D, Theobald D, Everitt BJ. Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology. 2012 Oct;37(11):2505-14. doi: 10.1038/npp.2012.111. Epub 2012 Jul 4.
Results Reference
background
PubMed Identifier
23332512
Citation
Groman SM, James AS, Seu E, Crawford MA, Harpster SN, Jentsch JD. Monoamine levels within the orbitofrontal cortex and putamen interact to predict reversal learning performance. Biol Psychiatry. 2013 Apr 15;73(8):756-62. doi: 10.1016/j.biopsych.2012.12.002. Epub 2013 Jan 16.
Results Reference
background
PubMed Identifier
25869808
Citation
Worbe Y, Palminteri S, Savulich G, Daw ND, Fernandez-Egea E, Robbins TW, Voon V. Valence-dependent influence of serotonin depletion on model-based choice strategy. Mol Psychiatry. 2016 May;21(5):624-9. doi: 10.1038/mp.2015.46. Epub 2015 Apr 14.
Results Reference
background
PubMed Identifier
8597523
Citation
el Mansari M, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Relevance to treatment of obsessive-compulsive disorder. Neuropsychopharmacology. 1995 Oct;13(2):117-27. doi: 10.1016/0893-133X(95)00045-F.
Results Reference
background
PubMed Identifier
29666372
Citation
Lissemore JI, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl TE, Pinard G, Sibon I, Cottraux J, Leyton M, Benkelfat C. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline. Transl Psychiatry. 2018 Apr 18;8(1):82. doi: 10.1038/s41398-018-0128-4.
Results Reference
background
PubMed Identifier
25567322
Citation
Banca P, Voon V, Vestergaard MD, Philipiak G, Almeida I, Pocinho F, Relvas J, Castelo-Branco M. Imbalance in habitual versus goal directed neural systems during symptom provocation in obsessive-compulsive disorder. Brain. 2015 Mar;138(Pt 3):798-811. doi: 10.1093/brain/awu379. Epub 2015 Jan 6.
Results Reference
background
PubMed Identifier
21572165
Citation
Gillan CM, Papmeyer M, Morein-Zamir S, Sahakian BJ, Fineberg NA, Robbins TW, de Wit S. Disruption in the balance between goal-directed behavior and habit learning in obsessive-compulsive disorder. Am J Psychiatry. 2011 Jul;168(7):718-26. doi: 10.1176/appi.ajp.2011.10071062. Epub 2011 May 15.
Results Reference
background
PubMed Identifier
28265059
Citation
Apergis-Schoute AM, Gillan CM, Fineberg NA, Fernandez-Egea E, Sahakian BJ, Robbins TW. Neural basis of impaired safety signaling in Obsessive Compulsive Disorder. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3216-3221. doi: 10.1073/pnas.1609194114. Epub 2017 Mar 6.
Results Reference
background
PubMed Identifier
16816237
Citation
Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry. 2006 Jul;163(7):1282-4. doi: 10.1176/ajp.2006.163.7.1282.
Results Reference
background
PubMed Identifier
17267798
Citation
Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ. Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Feb;164(2):335-8. doi: 10.1176/ajp.2007.164.2.335.
Results Reference
background
PubMed Identifier
27769568
Citation
Vaghi MM, Vertes PE, Kitzbichler MG, Apergis-Schoute AM, van der Flier FE, Fineberg NA, Sule A, Zaman R, Voon V, Kundu P, Bullmore ET, Robbins TW. Specific Frontostriatal Circuits for Impaired Cognitive Flexibility and Goal-Directed Planning in Obsessive-Compulsive Disorder: Evidence From Resting-State Functional Connectivity. Biol Psychiatry. 2017 Apr 15;81(8):708-717. doi: 10.1016/j.biopsych.2016.08.009. Epub 2016 Aug 11.
Results Reference
background
PubMed Identifier
2510699
Citation
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry. 1989 Nov;46(11):1012-6. doi: 10.1001/archpsyc.1989.01810110054008.
Results Reference
background
PubMed Identifier
24189342
Citation
Haahr ME, Fisher PM, Jensen CG, Frokjaer VG, Mahon BM, Madsen K, Baare WF, Lehel S, Norremolle A, Rabiner EA, Knudsen GM. Central 5-HT4 receptor binding as biomarker of serotonergic tonus in humans: a [11C]SB207145 PET study. Mol Psychiatry. 2014 Apr;19(4):427-32. doi: 10.1038/mp.2013.147. Epub 2013 Nov 5.
Results Reference
background
Citation
Foa, E. B. et al. The validation of a new obsessive-compulsive disorder scale: The obsessive-compulsive inventory. Psychological Assessment 10(3), 206-214, 1998.
Results Reference
background

Learn more about this trial

The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain Mechanisms

We'll reach out to this number within 24 hrs